Trusted Press Release Distribution   Plans | Login    

Briefing Search


Author Details
Credence Research
Chris Smith
105 N 1st ST #429, SAN JOSE,, CA 95103, United States

Bookmark and Share
Respiratory Tract Infection Treatment Market Report Just Published by Credence Research Inc.
Respiratory Tract Infection Treatment Market: Global Market Size, Market Share, Growth and Forecast to 2025, 10/12/2018 - The latest market report published by Credence Research, Inc. “Global Respiratory Tract Infection Treatment Market was valued at US$ 34,276.8 Mn in 2016, and is expected to reach US$ 59,957.3 Mn by 2025 expanding at a CAGR of 6.2 % from 2017 to 2025.

Credence Research, the leading business intelligence provider, has published its latest research, "Respiratory Tract Infection Treatment Market 2025", which gives insights into Respiratory Tract Infection Treatment in the Global market. The report determines the market size for 2018, along with forecasts until 2025. It is built using data and information sourced from exclusive databases, primary and secondary research, and in-house analysis carried out by Credence Research’s team of industry experts.

Market Insights:

Microbes gain entry to the respiratory tract by inhalation of droplets and invade the mucosa. Causative agents of lower respiratory infections are viral or bacterial. Symptoms include cough, fever, chest pain, tachypnea and sputum production. Patients with pneumonia may also exhibit non-respiratory symptoms such as confusion, headache, myalgia, abdominal pain, nausea, vomiting and diarrhea. In base year 2016, the upper respiratory tract infection are leading the disease segment due to factors such as constant climate change and air pollution, gross negligence when it comes to personal hygiene like sneezing, coughing (uncovered face) and touching inanimate objects with contaminated hands.

Get Sample: [URL][/URL]

Lower respiratory tract infection are anticipated to register faster growth in the disease segment throughout the forecast period 2017-2025, due to factors like rising number of air particulate matter, which causes respiratory tract irritation and infection and on the basis of transmission it might be hospital acquired, ventilator acquired, and community acquired.

In 2016, NSAIDs holds the largest market in the drug class segment due to factors such as low cost and easy availability as OTC products, technological advancement in the drug formulation e.g. ketorolac nasal spray to overcome NSAIDs adverse events.

Leading Players:

major players such as Abbott Laboratories, AstraZeneca, Boehringer Ingelheim GmbH, Pfizer, Inc., Sanofi, Teva Pharmaceutical Industries Ltd. are few market leaders in respiratory tract infection treatment and compete to augment their foothold in the market.


• The report presents the brief overview of Respiratory Tract Infection Treatment Market including business description, key information and facts, and its locations and subsidiaries

• The report features product description and descriptive mechanism of action for key products along with the products developmental history and major milestones

• Special feature on out-licensed and partnered product portfolio

• The report summarizes all the dormant and discontinued projects

• Latest company statement

• Latest news and deals relating to the Respiratory Tract Infection Treatment products

Browse full report: [URL][/URL]

LinkedIn: [URL][/URL]

FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2019 Proserve Technology, Inc.